BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36337706)

  • 1. State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us.
    Unda SR; Marciano S; Milner TA; Marongiu R
    Front Aging Neurosci; 2022; 14():971007. PubMed ID: 36337706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopause and disorders of the central nervous system.
    Henderson VW
    Minerva Ginecol; 2005 Dec; 57(6):579-92. PubMed ID: 16306863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis.
    Wu M; Li M; Yuan J; Liang S; Chen Z; Ye M; Ryan PM; Clark C; Tan SC; Rahmani J; Varkaneh HK; Bhagavathula AS
    Pharmacol Res; 2020 May; 155():104693. PubMed ID: 32057896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and other neurological disorders.
    Henderson VW
    Climacteric; 2007 Oct; 10 Suppl 2():92-6. PubMed ID: 17882682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Image in Women with Parkinson's Disease.
    Mathur S; LaMonica K; Matthews H; Hill K
    J Parkinsons Dis; 2023; 13(3):329-332. PubMed ID: 36911949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Menstrual Cycle on Neurological Disorders.
    Roeder HJ; Leira EC
    Curr Neurol Neurosci Rep; 2021 May; 21(7):34. PubMed ID: 33970361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.
    Atwood CS; Bowen RL
    Horm Behav; 2015 Nov; 76():63-80. PubMed ID: 26188949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.
    Sveinsdóttir H; Olafsson RF
    J Adv Nurs; 2006 Jun; 54(5):572-84. PubMed ID: 16722955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormones and cognition in aging.
    Gurvich C; Le J; Thomas N; Thomas EHX; Kulkarni J
    Vitam Horm; 2021; 115():511-533. PubMed ID: 33706960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
    Kusters CDJ; Paul KC; Duarte Folle A; Keener AM; Bronstein JM; Bertram L; Hansen J; Horvath S; Sinsheimer JS; Lill CM; Ritz BR
    Mov Disord; 2021 Oct; 36(10):2264-2272. PubMed ID: 34426982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease: A Systematic Review.
    Cardinali CAEF; Martins YA; Torrão AS
    Drugs Aging; 2021 Sep; 38(9):769-791. PubMed ID: 34342862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease, menopause and the impact of the estrogenic environment.
    Pines A
    Climacteric; 2016 Oct; 19(5):430-2. PubMed ID: 27327261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis.
    Song YJ; Li SR; Li XW; Chen X; Wei ZX; Liu QS; Cheng Y
    Front Neurosci; 2020; 14():157. PubMed ID: 32210745
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications for estrogens in Parkinson's disease: an epidemiological approach.
    Ragonese P; D'Amelio M; Savettieri G
    Ann N Y Acad Sci; 2006 Nov; 1089():373-82. PubMed ID: 17261781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications and controindications of hormone replacement therapy in menopause].
    Fichera M; Rinaldi N; Tarascio M; Taschetta S; Caldaci LM; Catavorello A; La Rosa B; Panella MM
    Minerva Ginecol; 2013 Jun; 65(3):331-44. PubMed ID: 23689177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive factors and risk of Parkinson's disease in women: A meta-analysis of observational studies.
    Lv M; Zhang Y; Chen GC; Li G; Rui Y; Qin L; Wan Z
    Behav Brain Res; 2017 Sep; 335():103-110. PubMed ID: 28743601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Decline in Early and Premature Menopause.
    Sochocka M; Karska J; Pszczołowska M; Ochnik M; Fułek M; Fułek K; Kurpas D; Chojdak-Łukasiewicz J; Rosner-Tenerowicz A; Leszek J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.
    Henderson VW
    J Steroid Biochem Mol Biol; 2014 Jul; 142():99-106. PubMed ID: 23727128
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.